Virta Health Diabetes Reversal Program Provided for Employees
- Document date
- Jan 1, 2026
- Term
- January 1, 2026 – December 31, 2026
- Renews
- Free account
The 30-second brief
Romeo Community Schools employees have access to Virta Health's diabetes reversal program as part of the BCBSM/WMHIP medical plan for 2026.
Virta Health holds this contract with Romeo Community Schools. Its other public contracts on record include work for Municipalities Colleges Schools Insurance Group and Lyons Unified School District 405.
The renewal date is on record. Get free alerts for pre-RFPs like this one, matched to what you sell.
Get pre-RFPs for work like this before the bid is out.
Get pre-RFP alerts freeFree account · 30-second setup · No credit card
Contract details
- Document date
- January 1, 2026
- Term
- January 1, 2026 – December 31, 2026
- Renews
- On record
- Vendor
- Virta Health
- Agency
- Romeo Community Schools
- Source document
- romeo_community_schools_2026_open_enrollment_benef.pdf (Report)
Virta Health's other public contracts
More Romeo Community Schools contracts
Questions about this contract
Who was awarded the government contract by Romeo Community Schools?
Virta Health was awarded this government contract by Romeo Community Schools, as recorded on January 1, 2026.
What type of contract is this?
This is a government contract, documented as a report record.
Where was this contract approved?
This contract appears in romeo_community_schools_2026_open_enrollment_benef.pdf (Report), dated January 1, 2026 from Romeo Community Schools. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What other contracts does Virta Health hold?
Virta Health may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
Show 1 more question
What is Romeo Community Schools currently buying?
Explore Romeo Community Schools's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.